2,198 reports of this reaction
1.9% of all VANCOMYCIN HYDROCHLORIDE reports
#9 most reported adverse reaction
PNEUMONIA is the #9 most commonly reported adverse reaction for VANCOMYCIN HYDROCHLORIDE, manufactured by Hikma Pharmaceuticals USA Inc.. There are 2,198 FDA adverse event reports linking VANCOMYCIN HYDROCHLORIDE to PNEUMONIA. This represents approximately 1.9% of all 116,197 adverse event reports for this drug.
VANCOMYCIN HYDROCHLORIDE has an overall safety score of 88 out of 100. Patients taking VANCOMYCIN HYDROCHLORIDE who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PNEUMONIA is a less commonly reported adverse event for VANCOMYCIN HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to pneumonia, the following adverse reactions have been reported for VANCOMYCIN HYDROCHLORIDE:
The following drugs have also been linked to pneumonia in FDA adverse event reports:
PNEUMONIA has been reported as an adverse event in 2,198 FDA reports for VANCOMYCIN HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PNEUMONIA accounts for approximately 1.9% of all adverse event reports for VANCOMYCIN HYDROCHLORIDE, making it a notable side effect.
If you experience pneumonia while taking VANCOMYCIN HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.